NASDAQ:ACRX
AcelRx Pharmaceuticals Stock News
$0.86
+0 (+0%)
At Close: Mar 27, 2024
AcelRx To Acquire Lowell For $32M, Announces Capital Raise Of $14M
07:51am, Monday, 15'th Nov 2021
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) has agreed to acquire privately-held Lowell Therapeutics Inc for approximately $32.5 million. The deal consideration includes approximately $26 million o
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
02:57pm, Sunday, 14'th Nov 2021 Benzinga
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Among the
AcelRx to Host Third Quarter 2021 Financial Results Call and Webcast on November 15, 2021
08:30am, Wednesday, 10'th Nov 2021
HAYWARD, Calif., Nov. 10, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release third quarter financial results be
AcelRx Pharmaceuticals: Is Wayne Gretzky Right Or The Puck?
12:22am, Saturday, 02'nd Oct 2021
DSUVIA 2q21 revenues were below my and market expectations. But management provided further details regarding the Europe out-licensing agreement for DSUVIA and the in-licensing agreements. And Formula
AcelRx Pharmaceuticals to Participate in Two September Investor Conferences
03:19pm, Friday, 10'th Sep 2021
HAYWARD, Calif., Sept. 10, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative
HAYWARD, Calif., Aug. 30, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovativ
HAYWARD, Calif., Aug. 26, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovativ
5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021
03:30pm, Wednesday, 18'th Aug 2021
Analysts say these are penny stocks to buy. Do you agree?
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2021 Results - Earnings Call Transcript
07:19pm, Monday, 16'th Aug 2021
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2021 Results - Earnings Call Transcript
AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Lags Revenue Estimates
07:03pm, Monday, 16'th Aug 2021
AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 0.00% and -19.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX) and certain of
Los Angeles, California--(Newsfile Corp. - August 9, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AcelRx Pharmaceutic
New York, New York--(Newsfile Corp. - August 9, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx"
New York, New York--(Newsfile Corp. - August 9, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) bet
New York, New York--(Newsfile Corp. - August 6, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) betw